1) End-stage liver disease model
终末期旰病模型
2) model for end-stage liver disease
终末期肝病模型
1.
A retrospective analysis of prognosis on patients with severe hepatitis using the model for end-stage liver disease;
重型肝炎的终末期肝病模型预后回顾性分析
2.
Objective To investigate the predictive value of model for end-stage liver disease(MELD) for the evaluation of the short-time outcome of patients underwent liver transplantation.
目的探讨术前终末期肝病模型(model for end-stage liver disease,MELD)评分在肝移植治疗终末期肝病早期预后中的预测价值。
3) Model for end-stage liver disease(MELD)
终末期肝病模型
1.
Objective: To investigate the relationship between the model for end-stage liver disease(MELD) and Child-Turcotte-Pugh(CTP) scoring,and the prognosis of patients with decompensated liver cirrhosis.
目的:研究终末期肝病模型(MELD)与Child-Turcotte-Pugh(CTP)评分系统和肝硬化失代偿期患者短期(3个月)预后的关系。
4) MELD
[英][meld] [美][mɛld]
终末期肝病模型
1.
MELD scoring system in evaluating the curative effect of MARS and prognosis of the patients with chronic severe hepatitis;
终末期肝病模型评分对慢性重型肝炎患者分子吸附循环系统疗效及预后的评价
2.
Objective To investigate the predicting the prognosis of model for end-stage liver disease (MELD and MELD-Na) of chronic severe hepatitis B under chemotherapy.
目的研究终末期肝病模型(MELD和MELD-Na)评分系统预测慢性乙型重型肝炎患者预后的价值。
3.
Objective To determine mortality rates,identify prognostic indicators,and determine the usefulness of these 3 scoring systems,the MELD,the Index and Child-Turcotte-Pugh(CTP)in predicting short-term(6-month)survival in Chinese patients with chronic hepatitis B related decompensation who were treated with lamivudine.
目的在中国人群中评价拉米夫定治疗失代偿乙型肝炎肝硬化早期(6个月)死亡率和相关预测因素,并对比终末期肝病模型(MELD)、Index指数(Index)和Child-Turcotte-Pugh肝功能分级(CTP)三种评判模型对早期死亡的预测效果。
5) model for end-stage liver disease (MELD)
终末期肝病模型(MELD)
6) model for end-stage liver disease score
终末期肝病模型评分
1.
Model for end-stage liver disease score in predicting acute kidney injury and prognosis in patients receiving liver transplantation
终末期肝病模型评分在预测肝移植患者术后急性肾损伤的发生及预后中的价值
补充资料：朝旰
1.早晩。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条